Ajanta Pharma Buyback Record Date 2024, Price, Entitlement Ratio

0

Last updated on June 3, 2024

Ajanta Pharma Buyback Record Date

Ajanta Pharma Buyback Record Date is finalized. 

Ajanta Pharma is a specialty pharmaceutical formulation company engaged in developing, manufacturing, and marketing finished dosages. The company has a well-diversified business model regarding markets, therapies, and products.

The company has de-risked the business to a large extent from possible uncertainties in the business environment in different geographies. The largest contribution of about 73% of business comes from a wide range of branded generic products in around 30 Asian countries (including India) and Africa.

Each geography has been carefully chosen for therapies and products. Additionally, about 21% comes from the generics business in the world’s largest market the USA, and the remaining 6% comes from anti-malaria institutional business in Africa.

Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India. Out of this, 6 facilities manufacture finished formulations and 1 manufactures Active Pharmaceutical Ingredients (APIs), primarily for captive consumption.

Ajanta Pharma Limited

Ajanta Pharma Buyback Record Date, Other Details

Ajanta Pharma Buyback Dates5 – 11 June 2024
Ajanta Pharma Buyback Price INR 2,770 per share
Market Price on Buyback ApprovalINR 2,233.10 per share
Buyback Premium on Market Price18.73%
Buyback Offer Size (Shares)1,028,881 shares
Buyback Offer Size (Amount)INR 285 crore
Offer TypeTender Offer
Promoter ParticipationYes
Face Value INR 2 per share
Listing AtBSE, NSE

Ajanta Pharma Buyback Dates (Timeline)

Board Meeting Intimation for Buyback Proposal26 April 2024
Buyback Approval Date2 May 2024
Public Announcement of Buyback6 May 2024
Ajanta Pharma Buyback Record Date30 May 2024
Buyback Opening Date5 June 2024
Buyback Closing Date11 June 2024
Cut-off Date to receive completed tender forms by Registrar11 June 2024
Verification Date by the Registrar17 June 2024
Return of unaccepted shares by Registrar19 June 2024
Extinguishment of accepted shares28 June 2024

Ajanta Pharma Buyback 2024 Documents

Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback


Ajanta Pharma Buyback Entitlement Ratio

Shareholder CategoryEntitlement RatioEntitlement Ratio (in %)
Small Shareholders
(less than INR 2 Lakh on record date)
1/812.5
General category
(for all other Eligible Shareholders)
1/1280.78

A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.


Ajanta Pharma Financial Performance

FY 2022FY 2023FY 2024
Revenue3,340.993,742.644,208.71
Total Expenses2,411.692,959.393,036.77
Net income 712.68587.98816.17
Figures in INR Crores unless specified otherwise

Calculation of Investment in Buyback

Maximum market value of a shareholder as on record dateINR 2,00,000
Buyback price per shareINR 2,770
Maximum shares for small shareholders (2,00,000/2,770) 73 shares *
The closing price of the stock as of 2 May 2024INR 2,233.10**
Maximum amount invested in buyback (INR 2,233.10 x 73 shares)INR 1,63,016
* No. of shares stands to change according to the closing price on the record date
** For simplicity, we have considered the
price on the buyback approval date

Ajanta Pharma Buyback Acceptance Ratio

Shares Tendered Buyback EntitlementAcceptance ratioBuyback ProfitProfit in %
731010 (100%)5,369.03.29
731020 (200%)10,738.06.59
731030 (300%)16,107.09.88

Registrar of Ajanta Pharma Buyback 2024

LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in


Manager of Ajanta Pharma Buyback 2024

VIVRO FINANCIAL SERVICES PRIVATE LIMITED
607/608 Marathon Icon, Opp. Peninsula
Corporate Park Off. Ganpatrao Kadam Marg,
Veer Santaji Lane, Lower Parel,
Mumbai-400 013, Maharashtra, India
Phone: +91 22 6666 8040/41/42
Email[email protected]
Website: www.vivro.net


Process to Participate in Ajanta Pharma Buyback

All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.

The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.


Frequently Asked Questions

What are Ajanta Pharma buyback dates?

Ajanta Pharma’s share buyback opens on 5 June 2024 and closes on 11 June 2024.

Which type of buyback is Ajanta Pharma buyback offer?

Ajanta Pharma’s buyback is a tender offer.

What is Ajanta Pharma buyback price?

Ajanta Pharma buyback price is INR 2,770 per share.

What is Ajanta Pharma buyback record date?

Ajanta Pharma buyback record date is 30 May 2024.

How to participate in Ajanta Pharma share buyback?

Ajanta Pharma’s share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.

LEAVE A REPLY

Please enter your comment!
Please enter your name here